ARTICLE | Company News
MolSoft LLC, Syrrx deal
November 6, 2000 8:00 AM UTC
The companies signed a 10-year agreement to accelerate structure-guided drug discovery by combining MolSoft’s Virtual Ligand Screening technology with Syrrx’s high throughput structural proteomics pla...